Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.

類似資料

• Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
  著者:: Natalie J. Hannan, 等
  出版事項: (2017-05-01)
• Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
  著者:: Tu'uhevaha J Kaitu'u-Lino, 等
  出版事項: (2018-01-01)
• Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
  著者:: Roxanne Hastie, 等
  出版事項: (2022-08-01)
• Placental galectin-3 is reduced in early-onset preeclampsia
  著者:: Manju Kandel, 等
  出版事項: (2022-10-01)
• Measuring circulating miRNAs in early pregnancy could identify fetuses’ destined to undergrow and be at increased risk of stillbirth
  著者:: Stephen Tong, 等
  出版事項: (2021-01-01)